Cargando…

The safety profile of drotrecogin alfa (activated)

Continued safety assessment is essential for any newly approved therapy. Drotrecogin alfa (activated; DrotAA), which is approved for use in severe sepsis, has undergone clinical trials with corresponding safety analyses since 1995. However, the only comprehensive review of all trials is that reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fumagalli, Roberto, Mignini, Mariano A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230610/
https://www.ncbi.nlm.nih.gov/pubmed/18269693
http://dx.doi.org/10.1186/cc6157

Ejemplares similares